NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

There are two simple and independently verifiable facts that can clear up this line of disinformation: 1. Liau & Ashkan are clinical trial experts. 2. rGBM has no treatment at all.

Below are pasted factual starting points to verify these two points. There are many other searchable sources beyond these:

1. Liau and Ashkan are both world-renowned CLINICAL TRIAL EXPERTS:

Dr. Linda Liau is a world-renowned neuro-oncologist, surgeon, and educator at UCLA where she is also the chair of the department of neurosurgery. As her paper on DCVax moves through the independent peer review process, it is interesting to note that she was once the editor-in-chief of a neuro-oncology medical journal.

https://www.uclahealth.org/providers/linda-liau

https://doi.org/10.3171/2020.12.FOCUS20954

https://soc-neuro-onc.org/

Across the pond from Dr. Liau, Dr. Ashkan was the chief investigator of the DCVax trial for patients in Europe. At King’s College in London, Ashkan is the lead clinician for neuro-oncology and the chair of the King’s Neurosciences Clinical Trial Unit. He is a world-renowned cancer trial expert. A few years ago, Professor Ashkan was named the UK Clinician of the Year by The Brain Tumour Charity. Additionally, Ashkan serves as an advisor to the U.K. government.

https://www.kcl.ac.uk/people/keyoumars-ashkan

2. We are talking about GBM and rGBM. The latter does not even have a “SOC” to extend life at all. Dr. Stupp created the SOC for GBM and he admits that SOC is useless for rGBM.

Dr. Stupp asserts that rGBM is a “major unmet need” (minute 13:35) He highlights that no SOC treatment works for recurrent & that survival is always the same with current therapies (14:36). He asserts that bureaucracy obstructs new advances.

https://www.youtube.com/embed/aHBkOhkKsrk